v3.25.1
Consolidated Statements of Cash Flows - USD ($)
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net loss from continuing operations $ (13,904,584) $ (15,507,748)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation 18,865 18,290
Amortization expense 630,164 630,164
Stock-based compensation 773,693 592,269
Change in fair value of warrant liabilities 77,806 (56,245)
Gain on sale of assets (65,048)
Changes in operating assets and liabilities:    
Prepaid expenses (86,746) 346,480
Other assets 2,262 158,285
Accounts payable and accrued liabilities (1,432,489) 1,070,967
Lease liabilities (2,409) (1,547)
Net cash used in operating activities (13,923,438) (12,814,133)
CASH FLOWS FROM INVESTING ACTIVITIES:    
Purchase of property and equipment (34,301)
Net cash proceeds from sale of assets 109,500
Net cash provided by investing activities 75,199
CASH FLOWS FROM FINANCING ACTIVITIES:    
Proceeds from sale of September 2024 Offering warrants 4,998,784
Proceeds from exercises of pre-funded warrants 349
Payment of offering costs in connection with September 2024 Offering warrants (481,499)
Note payable proceeds 392,354
Principal payments on note payable (392,354)
Repurchase of common stock (3,726,416)
Net cash provided by (used in) financing activities 4,517,634 (3,726,416)
Effect of foreign currency translation on cash (2,519) (3,991)
Net cash used in operating activities of discontinued operations 0 (611,278)
Net cash provided by investing activities of discontinued operations 0 323,807
Net cash provided by (used in) financing activities of discontinued operations 0 0
NET CHANGE IN CASH (9,408,323) (16,756,812)
Cash - Beginning of period 16,331,052 33,087,864
Cash - End of period 6,922,729 16,331,052
Supplemental disclosure of cash flow information:    
Amount due from sale of assets 40,500
Deemed dividend – warrant modification $ (359,656)

Source